[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556693":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":51,"collaborators":53,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":10,"eligibilityCriteria":88,"healthyVolunteers":89,"sex":90,"minAge":91,"maxAge":92,"enrollmentInfo":93,"targetDuration":10,"studyType":96,"phases":10,"briefSummary":97,"conditions":98,"keywords":115,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":130},{"fullName":5,"class":6},"ChromX Health","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"pulmonary disease",null,"Individuals with abnormalities in lung CT imaging and clinically diagnosed with lung cancer, lung infection, chronic obstructive pulmonary disease (COPD), bronchitis, pulmonary fibrosis, pulmonary embolism, pulmonary arterial hypertension, tuberculosis, lung abscess, emphysema, radioactive lung injury, cystic fibrosis of the lung, Bronchial Asthma, Bronchiectasis, interstitial lung disease (ILD), preserved ratio impaired spirometry (PRISm) etc .",[13],"Other: Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system",{"label":15,"type":10,"description":16,"interventionNames":17},"normal individual","Individuals with no abnormalities detected in lung CT imaging.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"OTHER","Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system","Exhaled breath samples from these participants will be collected and analyzed to detect volatile organic compound molecules in human exhaled breath by GC-MS and μGC-PID",[15,9],[25],{"name":26,"affiliation":27,"role":28},"Jianxing He, MD","The First Affiliated Hospital of Guangzhou Medical University","STUDY_CHAIR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Hengrui Liang, MD","CONTACT","+86 15625064712","hengrui_liang@163.com",[36],{"facility":27,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Guangzhou","Guangdong","510140","China","CN",{"type":44,"coordinates":45},"Point",[46,47],113.25,23.11667,{"lat":47,"lon":46},[50],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},{"type":52,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[54,55,57,59,62,64,66,68,70,72,74,76,78,80],{"name":27,"class":20},{"name":56,"class":20},"First People's Hospital of Foshan",{"name":58,"class":20},"Sichuan Cancer Hospital and Research Institute",{"name":60,"class":61},"Liwan District Central Hospital","UNKNOWN",{"name":63,"class":20},"Shanghai Chest Hospital",{"name":65,"class":20},"Peking Union Medical College Hospital",{"name":67,"class":61},"Guangzhou Development Zone Hospital",{"name":69,"class":61},"Huangpu District Hongshan Street Community Health Service Center",{"name":71,"class":61},"Huangpu District Chinese Medicine Hospital",{"name":73,"class":20},"Fifth Affiliated Hospital of Guangzhou Medical University",{"name":75,"class":61},"Huangpu District Jiufo Street Community Health Service Center",{"name":77,"class":61},"Huangpu District Xinlong Town Central Hospital",{"name":79,"class":61},"Huangpu District Yonghe Street Community Health Service Center",{"name":81,"class":61},"Huangpu District Lianhe Street Second Community Health Service Center","100556693","identification-of-multiple-pulmonary-diseases-using-volatile-organic-compounds-biomarkers-in-human-exhaled-breath-100556693",false,"NCT06528418","Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","Inclusion Criteria:\n\n* Males or females, age must be 18 years old or above.\n* Patients must meet the CT imaging diagnostic criteria for different lung diseases, and patients must be able to provide electronic versions of CT image data.\n* Patients must have a clear clinical diagnosis.\n* All participants must sign a written informed consent form.\n\nExclusion Criteria:\n\n* Pregnant women.\n* Individuals with a history of cancer other than lung disease.\n* Individuals who have undergone organ transplants or non-autologous (allogeneic) bone marrow or stem cell transplants.\n* Individuals with other severe organic diseases or mental illnesses.\n* Individuals with metabolic diseases such as diabetes, hyperlipidemia, etc.\n* Any other condition that researchers deem unsuitable for participation in this clinical trial.",true,"ALL","18 Years","100 Years",{"count":94,"type":95},10000,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are:\n\n1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases.\n2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.",[99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114],"Lung Cancer","Lung Infection","COPD","Bronchitis","Pulmonary Fibrosis","Pulmonary Embolism","Pulmonary Arterial Hypertension","Pulmonary Tuberculosis","Pulmonary Abscess","Emphysema","Lung Injury","Cystic Fibrosis of the Lung","Bronchial Asthma","Bronchiectasis","Interstitial Lung Disease","Preserved Ratio Impaired Spirometry",[116,117,118,119,120],"Pulmonary Disease","Volatile Organic Compounds","Human Exhaled Breath","micro Gas Chromatography-photoionisation","detector (μGC-PID) system","2025-03-23",{"date":123,"type":124},"2025-03-26","ACTUAL",{"date":126,"type":124},"2024-06-30",{"date":128,"type":95},"2027-06-30",{"name":5,"class":6},1]